IP Library Granted Patent US 10,759,739
Granted Patent B2
US 10,759,739 · App. 15/580,643 · Granted Sep 1, 2020

P62-ZZ small molecule modulators

Inventor: Xiangqun Xie (Sewickley, PA)
Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
C07C217/58A61K31/137A61K45/06A61P35/00C07C2601/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,759,739
App. No.
15/580,643
Granted
Sep 1, 2020
Kind
B2
Abstract

A compound, or a pharmaceutically acceptable salt thereof, having a formula I of: wherein Ar is an arylene or heteroarylene; R 1 has a structure of: wherein W is an alkanediyl, alkenediyl, a carbonyl, or a combination thereof; X is —NR 5 —, wherein R 5 is H or an alkyl, or —O—; and Y is optionally-substituted cycloalkyl, optionally-substituted cycloalkyl-substituted alkyl, optionally-substituted heterocycloalkyl, or optionally-substituted heterocycloalkyl-substituted alkyl; each R 2 is the same or different and has a structure of: wherein Z is —NR 6 —, wherein R 6 is H or an alkyl, —O—, —S—, or —CH 2 —; Z 1 is (—CH 2 —) m wherein m is 0 to 5, or an alkenediyl having 2 to 6 carbon atoms; Cy is a 3-8-membered cycloalkyl, heterocycloalkyl, aryl or heteroaryl ring; and each R 4 is the same or different and is selected from hydroxy, halogen, substituted or unsubstituted alkoxy, substituted or unsubstituted alkyl, or amino; and c is 0 to 5; and each R 3 is the same or different and is selected from hydroxy, halogen, substituted or unsubstituted alkoxy, substituted or unsubstituted alkyl, amino, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or a nitro, wherein a is 2 to 5, and b is 0 to 3.

Claims (42)

1. A compound, or a pharmaceutically acceptable salt thereof, having a formula I of:

wherein Ar is benzenetriyl;

R 1 has a structure of: CH 2 —X—(CH 2 ) m —R 11 , wherein X is NH or O, m is 0 to 6, and R 11 is optionally-substituted cycloalkyl;

each R 2 is the same or different and has a structure of:

wherein Z is —O—;

Z 1 is (—CH 2 —) m ;

Cy is phenyl; and

each R 4 is the same or different and is selected from hydroxy, halogen, substituted or unsubstituted alkoxy, substituted or unsubstituted alkyl, or amino; and c is 1 to 5; and

each R 3 is the same or different and is selected from hydroxy, halogen, substituted or unsubstituted alkoxy, substituted or unsubstituted alkyl, amino, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or a nitro,

wherein a is 2, and b is 0.

2. The compound of claim 1 , wherein a first R 2 group is in a meta position on the Ar ring relative to the R 1 group, and a second R 2 group is in a para position on the Ar ring relative to the R 1 group.

3. The compound of claim 1 , wherein R 4 is —F, —Cl, —OCH 3 , —OH, —CH 3 or —NH 2 .

4. The compound of claim 1 , wherein c is 1 and R 4 is 4-fluoro, or 4-methyl.

5. The compound of claim 1 , wherein c is 2 and R 4 is 2, 4-difluoro.

6. The compound of claim 1 , wherein R 11 is

and m is 0 or 1.

7. The compound of claim 1 , wherein each R 2 group has the same structure.

8. The compound of claim 1 , having a structure of:

wherein each of R 7 , R 8 , and R 9 are the same or different and are selected from —F, —Cl, —OCH 3 , —OH, —CH 3 , or —NH 2 ; d is 0; e is 1 to 5; f is 1 to 5; m is 0 or 1; and R 11 is optionally-substituted cycloalkyl.

9. The compound of claim 1 , having a structure of:

wherein each of R 7 , R 8 , and R 9 are the same or different and are selected from —F, —Cl, —OCH 3 , —OH, —CH 3 , or —NH 2 ; d is 0 to 3; e is 1 to 5; f is 1 to 5; m is 0 or 1; and R 11 is optionally-substituted cycloalkyl.

10. The compound of claim 8 , wherein R 11 is

11. The compound of claim 1 , selected from:

12. A compound, or a pharmaceutically acceptable salt thereof, having a formula I of:

wherein Ar is benzenetriyl;

R 1 has a structure of:

wherein W is —CH 2 —;

X is —NR 5 —, wherein R 5 is H or an alkyl, or —O—; and

Y is

each R 2 is the same or different and has a structure of:

wherein Z is —O—;

Z 1 is (—CH 2 —) m wherein m is 1; Cy is phenyl; and

each R 4 is the same or different and is selected from hydroxy, halogen, substituted or unsubstituted alkoxy, substituted or unsubstituted alkyl, or amino; and c is 0 to 5; and

each R 3 is the same or different and is selected from hydroxy, halogen, substituted or unsubstituted alkoxy, substituted or unsubstituted alkyl, amino, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or a nitro,

wherein a is 2 to 5, and b is 0 to 3.

13. The compound of claim 12 , wherein X is —NR 5 —, wherein

R 5 is H.

14. The compound of claim 1 , wherein the compound is:

15. The compound of claim 12 , wherein a is 2 and b is 0.

16. The compound of claim 12 , wherein R 4 is —F, —Cl, —OCH 3 , —OH, —CH 3 or —NH 2 .

17. The compound of claim 12 , wherein c is 1 and R 4 is 4-fluoro, or 4-methyl.

18. The compound of claim 12 , wherein c is 2 and R 4 is 2, 4-difluoro.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2024
From: XIE, XIANGQUN
To: ID4PHARMA, LLC
Reel/Frame 068553/0904 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2024
From: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
To: XIE, XIANGQUN
Reel/Frame 066017/0125 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2017
From: XIE, XIANGQUN
To: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 044402/0898 →
Continuity (2)
Provisional Application 62174465 · Jun 11, 2015
Related Publication 20180265452A1 · Sep 20, 2018